topic

967 Inflammatory tumour microenvironment in CRC alters macrophage function through mesenchymal stromal cell PD-1/PD-L1 signalling
Niamh Leonard, Shania Corry, Oliver Treacy, Eileen Reidy, Keara Redmond, Hannah Egan, Margaret Sheehan, Aoife Canney, Aisling Hogan, Daniela Loessner, Laurence Egan, Sean Hynes, Thomas Ritter, Philip Dunne, Aideen E Ryan

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1074; DOI: 10.1136/jitc-2023-SITC2023.0967
968 PD-1^hiFoxp3^-CD4⁺ tumor-infiltrating T-cell lineage commitment impacts the immunotherapy outcome
Levi Mark Mangarin, Stephen Martis, Andrea Orlando, Sara Schad, Jedd D Wolchok, Benjamin Greenbaum, Taha Merghoub, Roberta Zappasodi

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1075; DOI: 10.1136/jitc-2023-SITC2023.0968
969 Patient-specific immune cell radiosensitivity ratio necessary for predicting radiotherapy outcomes in lung cancer: a mathematical modeling study
Saket Pandit, Heiko Enderling

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1076; DOI: 10.1136/jitc-2023-SITC2023.0969
970 Multiplex-immunofluorescence-based spatial characterization of the tumor-microenvironment of a large bicentric clinical non-small cell lung cancer cohort
Simon Schallenberg, Gabriel Dernbach, Sharon Ruane, Cornelius Böhm, Lukas Ruff, Kai Standvoss, Sandip Ghosh, Mihnea P Dragomir, Rebecca Fritz, Ines Koch, Corinna Friedrich, Sabine Merkelbach-Bruse, Alexander Quaas, Nikolaj Frost, Kyrill Boschung, Winfried Randerath, Georg Schlachtenberger, Matthias Heldwein, Ulrich Keilholz, Khosro Hekmat, Jens-Carsten Rückert, Reinhard Büttner, Angela Vasaturo, David Horst, Maximilian Alber, Frederick Klauschen

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1077; DOI: 10.1136/jitc-2023-SITC2023.0970
971 Immature neutrophils inhibit anti-tumor immunity and impede checkpoint blockade therapy in bone metastases
Tao Shi, Kaijie Liang, Yipeng Zhang, Xiaoyu Zhou, Baorui Liu, Jia Wei

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1078; DOI: 10.1136/jitc-2023-SITC2023.0971
972 Platinum-based chemotherapy reverses human MDSC phenotype and suppressive activity on CD8+ T cells
Yueyun Ding, Ailem Schrand, Joe DeBettencourt, Ana Lako, Sharmila Chamling Rai, Christine Tauras, Zoe Bleicher, Timothy Consedine, Sangeeth George, David Balli, Tyler Simpson, William J Geese, Rupal Bhatt, Benjamin Chen, Noe Ramirez-Alejo

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1079; DOI: 10.1136/jitc-2023-SITC2023.0972
973 Phenotypical differences of neutrophils in tumour-draining lymph nodes in head and neck cancer
Sandra Ekstedt, Krzysztof Piersiala, Susanna Kumlien Georén, Lars Olaf Cardell

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1080; DOI: 10.1136/jitc-2023-SITC2023.0973
974 Single cell analysis of neutrophil heterogeneity reveals anti-tumoral phenotypes and its implications for immune-checkpoint blockade therapy in head and neck cancer
Anqi Gao, Wei Wang, Athena Golfinos, Paul Lambert, Huy Q Dinh

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1081; DOI: 10.1136/jitc-2023-SITC2023.0974
975 Activation of myeloid cells by β-glucan clears disseminating ovarian cancer cells from the peritoneal fluid through macrophage-mediated clotting and omentum neutrophil extracellular traps
Brennah Murphy, Taito Miyamoto, Bryan Manning, Rugang Zhang, Yulia Nefedova, Nan Zhang

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1082; DOI: 10.1136/jitc-2023-SITC2023.0975
976 Xenoestrogen potentiates the polarization of M2 macrophage via ESR1/p300 axis-mediated histone lactylation
Fang-Ju Cheng, Wei-Chien Huang

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1083; DOI: 10.1136/jitc-2023-SITC2023.0976

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages